A new approach to support specialist prescribing of bDMARDs
Arthritis Australia is part of an eight-member Consortium led by NPS MedicineWise, which is the successful recipient of the ‘Value in Prescribing biological disease-modifying anti-rheumatic drugs (bDMARDs)’ government grant.
The grant will fund a project to improve the use of bDMARDs to ensure the best health and economic outcomes from investment in these therapies.
NPS MedicineWise media release – bDMARDS September 2019 (002)
Discover more...
-
National Research Program information session for researchers
We are committed to improving the lives of Australians living with arthritis and musculoskeletal conditions through impactful, relevant research. We’re excited to announce our new...
-
New Website Empowers Australians with Osteoarthritis
Press Release [Sydney, Australia] Australians living with osteoarthritis now have a powerful new resource at their fingertips with the launch of MyOA/ MyJointPain (https://myoa.org.au/), a...
-
Men’s Health Week: The Reality of Arthritis for Australian Men – what the numbers say
Having arthritis is tough. But is pushing through pain really a badge of honour? This Men’s Health Week, it’s time for a reality check. The...
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox:
